News
-
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells
Telomir-1 by Telomir Pharmaceuticals demonstrates tumor growth inhibition by 50% in prostate cancer model, suppresses cancer progression, and neutralizes chemotherapy toxicity, providing breakthrough findings -
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines
Telomir Pharmaceuticals announces new study findings showing Telomir-1 reverses oxidative stress, prevents cell death, and protects mitochondria, offering broad-spectrum therapeutic potential -
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market
Telomir Pharmaceuticals, Inc. announces breakthrough in stabilizing Silver(II) for medical use, revolutionizing antimicrobial treatments & wound care solutions -
